Continuing Medical Education
Cleveland Clinic Center for Continuing Education
The Center for Continuing Education is committed to sharing a wealth of knowledge with physicians, nurses, and other medical professionals worldwide for more than 80 years. Its objective is to provide high-quality, innovative educational programs that increase the knowledge of health care providers, resulting in improved patient outcomes.
American Society of Clinical Oncology (ASCO)
Featured Abstracts from the 2020 Annual Meeting
- Mortality Risk Factors in Patients with Cancer and COVID-19
- Neoadjuvant and Adjuvant Combination Therapy in Locally Advanced Renal Cell Carcinoma Raises Toxicity Concerns
- Combination Therapy Shows Promising Results in Some Higher-Risk Leukemias
- Phase II Trial Evaluates Safety of Pembrolizumab plus SurVaxM in Recurrent Glioblastoma
- Cohorts Worth Screening After Definitive Head and Neck Squamous Cell Carcinoma Treatment
- Top Abstracts from ASCO 2020
American Society for Radiation Oncology (ASTRO)
Featured Abstracts from the 2019 Annual Meeting
- Using Artificial Intelligence to Deliver Personalized Radiation Therapy
- High-Dose Neoadjuvant Radiosurgery for Brain Metastases Appears Safe, Effective in Early Results from Phase 1/2 Study
- Postprostatectomy Prostate-Specific Antigen Kinetics Associated with Recurrence After Salvage Radiation
- Preoperative Pelvic Radiation is Safe, Effective in Patients with IBD and Rectal Cancer
- Stereotactic Body Radiation Therapy: A Promising Approach for Pediatric Patients
- Metabolic Reprogramming: A Promising Approach to Tackling Therapeutic Resistance in Glioblastoma
- Automated Screening Reduces Errors in Radiation Treatment Planning
American Society of Hematology (ASH)
Featured Abstracts from the 2019 Annual Meeting
- Pediatric-inspired Post-remission Chemotherapy Superior to Stem Cell Transplantation for Young Adults with ALL
- Studies' Results Support Liberalization of Some Eligibility Criteria for Acute Myeloid Leukemia Clinical Trials
- Treatment for Myelofibrosis-Associated Anemia on the Horizon
- Findings Suggest CAR T-Cell Therapy is Highly Effective for Relapsed/Refractory Mantle Cell Lymphoma
- Lenalidomide/Monoclonal Antibody Combination Superior to PI3K Inhibitor Monotherapy as First Novel Agent in Relapsed Follicular Lymphoma
